Clinical Trial Update: Breast Cancer Tumor Care Observational Programme

View source ↗

Summary

The Breast Cancer Tumor Care Observational Programme, sponsored by AstraZeneca, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Post Menopausal, Arthralgia | Status: COMPLETED